Radiological and functional outcomes associated with bridging therapy in stroke with unknown onset

Takeaway

  • Bridging therapy (BT), compared with direct mechanical thrombectomy (MT), was associated with better 3-month functional outcomes and a higher successful recanalization rate in stroke patients with unknown onset with intracranial internal carotid artery (ICA), M1-segment middle cerebral artery (M1-MCA), or M2-segment MCA (M2-MCA) occlusion and 10-Point Alberta Stroke Program Early CT Score (ASPECTS; 10PA), who received endovascular therapy (EVT) within 6 hours of symptom recognition or awakening.

Why this matters

    No data are currently available concerning safety and efficacy of BT in stroke patients with unknown symptom onset and normal computed tomography (CT) scan. Understanding clinical outcomes may improve treatment in this patient population.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.